Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02238951 · ClinicalTrials.gov registry record · NA

Cancer Care Coordination for Chemotherapy Patients

A NA study of Cancer, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02238951: Completed NA study of Cancer, sponsored by University of California, Davis.

NCT02238951 is a NA study of Cancer that has completed, run by University of California, Davis. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02238951, a NA study of Cancer, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.

Primary Outcome

Pain

Conditions Studied

Interventions

  • OTHER Mobile Health (mHealth)
  • OTHER No mHealth

Study Locations (1)

California

  • UC Davis Comprehensive Cancer Care Center - Sacramento

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-12
Est. Completion 2017-10
Phase NA
University of California, Davis

657 total trials

What the finished NCT02238951 record still lists

NCT02238951 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Mobile Health (mHealth) is the first listed.

NCT02238951 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02238951 about?

NCT02238951 is a clinical study titled "Cancer Care Coordination for Chemotherapy Patients". The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.

What is the current status of trial NCT02238951?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-12. Estimated completion is 2017-10.

What conditions does trial NCT02238951 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02238951?

The interventions under investigation include: Mobile Health (mHealth) (OTHER), No mHealth (OTHER).

Who is sponsoring clinical trial NCT02238951?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02238951 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02238951's enrollment target sits among peer trials

60 393rd of 615 higher than 208 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02238951, the US trial registry maintained by the National Library of Medicine. NCT02238951 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.